RecruitingNot ApplicableNCT07195656
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB) EVANESCE-II
Sponsor
FemPulse Corporation
Enrollment
151 participants
Start Date
Sep 30, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
A study to evaluate the safety and effectiveness of FemPulse System
Eligibility
Sex: FEMALEMin Age: 21 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Device Group and a drug called Medication Group for people with overactive bladder (oab). The study is currently recruiting participants at 15 locations. People eligible for this study include women aged 21 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEDevice Group
non-implanted, vaginal electrical stimulation device
DRUGMedication Group
OAB Medication
Locations(15)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07195656
Related Trials
PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
NCT067894065 locations
Aquarius Pilot Study to Evaluate the New Axonics Trial System
NCT073354842 locations
INOPASE - Performance and Safety Study of a Personalised SNM System
NCT071934072 locations
Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function
NCT069443921 location
Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women
NCT074733101 location